Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Lyden

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 1, 1990
Duplex carotid sonography. Peak systolic velocity in quantifying internal carotid artery stenosisC E Withers, B B Gosink, A M Keightley, et al.
Stroke|March 10, 2001
Clinical deterioration following improvement in the NINDS rt-PA Stroke TrialJ C Grotta, K M Welch, S C Fagan, et al.
Neurology|March 23, 2005
Prospective reliability of the STRokE DOC wireless/site independent telemedicine systemB C Meyer, P D Lyden, L Al-Khoury, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 8, 2010
Production and validation of Putonghua- and Cantonese-Chinese language National Institutes of Health Stroke Scale training and certification videosR T F Cheung, P D Lyden, T H Tsoi, et al.
Neuroscience|September 28, 2014
Protease activated receptor-1 mediates cytotoxicity during ischemia using in vivo and in vitro modelsP S Rajput, P D Lyden, B Chen, et al.
Neurology|May 1, 1989
Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbitsP D Lyden, J A Zivin, W A Clark, et al.
Stroke|February 24, 1998
Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS InvestigatorsK C Johnston, J Y Li, P D Lyden, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
Stroke|September 1, 1996
Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart AssociationH P Adams, T G Brott, A J Furlan, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 1, 1990
Duplex carotid sonography. Peak systolic velocity in quantifying internal carotid artery stenosisC E Withers, B B Gosink, A M Keightley, et al.
Stroke|March 10, 2001
Clinical deterioration following improvement in the NINDS rt-PA Stroke TrialJ C Grotta, K M Welch, S C Fagan, et al.
Neurology|March 23, 2005
Prospective reliability of the STRokE DOC wireless/site independent telemedicine systemB C Meyer, P D Lyden, L Al-Khoury, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 8, 2010
Production and validation of Putonghua- and Cantonese-Chinese language National Institutes of Health Stroke Scale training and certification videosR T F Cheung, P D Lyden, T H Tsoi, et al.
Neuroscience|September 28, 2014
Protease activated receptor-1 mediates cytotoxicity during ischemia using in vivo and in vitro modelsP S Rajput, P D Lyden, B Chen, et al.
Neurology|May 1, 1989
Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbitsP D Lyden, J A Zivin, W A Clark, et al.
Stroke|February 24, 1998
Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS InvestigatorsK C Johnston, J Y Li, P D Lyden, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
Stroke|September 1, 1996
Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart AssociationH P Adams, T G Brott, A J Furlan, et al.
Pageof 9